|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 06/05/15 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 29/04/15 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.07% | -1.39% | +0.42% | +21.16% | +5.50% | +2.09% | +20.24% | -24.61% | +204.56% | 48.84B | |
| +4.07% | +2.43% | +13.88% | +45.54% | +166.16% | +483.70% | +623.80% | +700.60% | - | 45.44B | |
| +4.33% | +0.98% | +16.18% | +23.61% | +19.32% | +12.80% | +88.53% | +28.76% | +1,184.59% | 41.22B | |
| +1.94% | -0.31% | +16.96% | +42.64% | +7.02% | +26.24% | +12.62% | -6.15% | +220.37% | 39.71B | |
| -0.50% | 0.00% | +14.33% | +11.78% | +16.60% | +20.60% | +60.49% | -10.77% | +151.13% | 32.6B | |
| +0.10% | -3.22% | -5.21% | +2.87% | - | - | - | - | - | 16.25B | |
| +3.22% | -0.88% | +11.04% | +43.79% | +6.32% | +30.42% | +135.47% | +232.75% | +2,021.96% | 16.67B | |
| -0.49% | -0.34% | -2.03% | +15.95% | +11.63% | +3.45% | +29.14% | -40.60% | +88.27% | 14.08B | |
| +2.35% | +3.48% | +27.76% | +90.02% | +43.69% | +82.95% | +43.41% | -31.34% | +245.68% | 13.68B | |
| +3.86% | +2.05% | -0.32% | +45.60% | -7.01% | -3.63% | -32.76% | -29.91% | +123.73% | 13.07B | |
| +2.02% | +6.55% | +41.23% | +88.45% | +76.26% | +65.76% | +77.19% | -37.60% | - | 12.37B | |
| -0.01% | +0.37% | +0.37% | +67.18% | +23.09% | +35.06% | -9.78% | -38.91% | +158.19% | 11.28B | |
| -0.90% | -4.59% | -11.13% | +9.78% | -12.83% | +75.80% | +513.74% | +296.79% | +2,398.81% | 10.57B | |
| +2.61% | +2.57% | +19.71% | +9.87% | +27.70% | +699.45% | +1,772.54% | +61.36% | - | 10.51B | |
| +0.03% | -0.04% | +0.44% | +65.87% | +78.31% | +260.93% | +470.30% | - | - | 10.15B | |
| +2.27% | +5.75% | +12.57% | +55.24% | +81.61% | +182.90% | +745.97% | +228.54% | +1,251.11% | 10.26B | |
| +3.42% | +11.82% | +4.87% | +47.68% | +56.03% | +184.80% | +541.70% | +132.81% | - | 10.1B | |
| +2.43% | +2.97% | +7.80% | -21.02% | -25.89% | +33.92% | +49.83% | +51.26% | +70.73% | 9.74B | |
| -0.68% | -6.21% | -1.58% | +17.55% | -12.55% | -30.01% | - | - | - | 9.32B | |
| Average | +1.58% | +1.05% | +8.81% | +35.98% | +31.17% | +120.40% | +302.50% | +94.56% | +676.59% | 18.79B | |
| Weighted average by Cap. | +1.79% | +0.61% | +9.99% | +33.84% | +37.26% | +116.15% | +232.88% | +119.88% | +584.93% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
